Xilio Therapeutics, Inc. (XLO)
0.6792
-0.03
(-4.38%)
USD |
NASDAQ |
Dec 12, 14:05
Xilio Therapeutics Total Liabilities (Quarterly): 141.79M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.08B |
| BioXcel Therapeutics, Inc. | 133.71M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
| Theriva Biologics, Inc. | 24.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.69M |
| Shareholders Equity (Quarterly) | -8.095M |
| Debt to Equity Ratio | -0.8972 |
| Current Ratio | 2.200 |
| Net Debt Paydown Yield | 0.65% |